Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden · Delayed Price · Currency is SEK 235.20
-0.40 (-0.17%)
Jul 24, 2026, 5:29 PM CET
Xvivo Perfusion AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 895.23 | 812.17 | 822.42 | 597.54 | 415.29 | 258.39 | |
Revenue Growth (YoY) | 8.79% | -1.25% | 37.63% | 43.89% | 60.72% | 43.66% |
Cost of Revenue | 248.23 | 212.67 | 206 | 152.43 | 118.34 | 70.11 |
Gross Profit | 647 | 599.49 | 616.42 | 445.11 | 296.96 | 188.28 |
Selling, General & Admin | 400.4 | 377.09 | 379.77 | 309.21 | 223.38 | 153.38 |
Depreciation & Amortization Expenses | 19.27 | - | - | - | - | - |
Research & Development | 137.47 | 131.99 | 148.33 | 135.94 | 69.34 | 54.04 |
Other Operating Expenses | -2.53 | 2.04 | -0.04 | -4.22 | -2.17 | -0.64 |
Total Operating Expenses | 554.61 | 511.12 | 528.06 | 440.92 | 290.55 | 206.78 |
Operating Income | 111.66 | 88.38 | 88.35 | 4.19 | 6.41 | -18.5 |
Interest Income | - | 39.14 | 147.5 | 136.62 | 71.6 | 45.37 |
Interest Expense | - | -88.96 | -35.91 | -46.28 | -55.69 | -20.21 |
Other Non-Operating Income (Expense) | 19.85 | -49.82 | 111.6 | 90.33 | 15.91 | 25.16 |
Total Non-Operating Income (Expense) | 19.85 | -99.63 | 223.19 | 180.67 | 31.81 | 50.33 |
Pretax Income | 131.52 | 38.56 | 199.95 | 94.52 | 22.31 | 6.67 |
Provision for Income Taxes | 42.95 | 13.4 | 27.77 | 2.7 | 3.89 | -1.49 |
Net Income | 88.57 | 25.16 | 172.18 | 91.82 | 18.43 | 8.15 |
Net Income to Common | 88.57 | 25.16 | 172.18 | 91.82 | 18.43 | 8.15 |
Net Income Growth | -20.48% | -85.39% | 87.52% | 398.29% | 126.04% | - |
Shares Outstanding (Basic) | 31 | 31 | 31 | 30 | 30 | 29 |
Shares Outstanding (Diluted) | 32 | 32 | 32 | 30 | 30 | 29 |
Shares Change (YoY) | -0.27% | -0.29% | 5.73% | 1.39% | 2.04% | 5.78% |
EPS (Basic) | 2.82 | 0.80 | 5.47 | 3.07 | 0.62 | 0.28 |
EPS (Diluted) | 2.82 | 0.80 | 5.44 | 3.07 | 0.62 | 0.28 |
EPS Growth | -19.89% | -85.29% | 77.20% | 395.16% | 121.43% | - |
Free Cash Flow | 236.35 | 7.35 | 40.56 | 3.27 | 9.67 | -22.25 |
Free Cash Flow Growth | 201.06% | -81.89% | 1139.58% | -66.17% | - | - |
Free Cash Flow Per Share | 7.49 | 0.23 | 1.28 | 0.11 | 0.33 | -0.77 |
Gross Margin | 72.27% | 73.81% | 74.95% | 74.49% | 71.51% | 72.87% |
Operating Margin | 12.47% | 10.88% | 10.74% | 0.70% | 1.54% | -7.16% |
Profit Margin | 9.89% | 3.10% | 20.94% | 15.37% | 4.44% | 3.15% |
FCF Margin | 26.40% | 0.90% | 4.93% | 0.55% | 2.33% | -8.61% |
EBITDA | 111.66 | 88.38 | 88.35 | 4.19 | 6.41 | -18.5 |
EBIT | 111.66 | 88.38 | 88.35 | 4.19 | 6.41 | -18.5 |
EBIT Margin | 12.47% | 10.88% | 10.74% | 0.70% | 1.54% | -7.16% |
Effective Tax Rate | 32.65% | 34.74% | 13.89% | 2.86% | 17.42% | -22.31% |